Bedside ultrasound-guided genicular nerve block with corticosteroids and lignocaine for knee osteoarthritis improves pain and participation, and is safe in inpatient rehabilitation: a retrospective case series.

IF 2.5 Q2 CLINICAL NEUROLOGY
Frontiers in pain research (Lausanne, Switzerland) Pub Date : 2025-05-13 eCollection Date: 2025-01-01 DOI:10.3389/fpain.2025.1601708
Edmund J R Neo, Trier T N Lau, Khin Yamin Thein, San San Tay
{"title":"Bedside ultrasound-guided genicular nerve block with corticosteroids and lignocaine for knee osteoarthritis improves pain and participation, and is safe in inpatient rehabilitation: a retrospective case series.","authors":"Edmund J R Neo, Trier T N Lau, Khin Yamin Thein, San San Tay","doi":"10.3389/fpain.2025.1601708","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Knee osteoarthritis (OA) is a common joint disorder that causes significant pain and disability. It can affect individuals undergoing inpatient rehabilitation, interfering with their participation in therapy and clinical improvement. While there are various treatment options available for this condition, such as the intra-articular corticosteroid injection, not all patients are suitable and symptoms may persist despite multimodal analgesia. The ultrasound-guided genicular nerve block (US GNB) induces analgesia by targeting the genicular nerves around the knee, and has emerged as a safe and effective intervention option. This is the first effort to document its application in the inpatient rehabilitation setting.</p><p><strong>Methods: </strong>This was a retrospective case series. We reviewed the medical records of inpatients undergoing rehabilitation who underwent the US GNB for disabling knee OA between July 1, 2022, and August 31, 2023. The primary outcome was improvement in rehabilitation participation based on physiotherapist notes in the week following the procedure. Secondary outcomes were pain by visual analogue scale (VAS), ambulation distance, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC), at pre-discharge, 1-month, and 3-month follow-up timepoints. Safety and adverse events were also retrospectively reviewed.</p><p><strong>Results: </strong>Nine patients were consented for recruitment in our study. Eight of them showed improvement in pain and/or participation in therapy. There were significant improvements in VAS scores (median change -3) and improvements in ambulation distance (median increase 8 m) between pre-injection and pre-discharge phases. However, these did not persist at the longer follow-up visits. There were no serious adverse events although 3 patients had recurrent pain at later dates, and required further procedures or surgical referral.</p><p><strong>Conclusions: </strong>The US GNB is safe to perform for inpatients undergoing rehabilitation who experience pain from knee OA. We found that in nearly all patients, there was clinical improvement in their pain and participation in therapy. It can be an effective alternative when other analgesia options are less desirable or available, and can help to keep patients progressing on the road to recovery.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"6 ","pages":"1601708"},"PeriodicalIF":2.5000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106467/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in pain research (Lausanne, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fpain.2025.1601708","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Knee osteoarthritis (OA) is a common joint disorder that causes significant pain and disability. It can affect individuals undergoing inpatient rehabilitation, interfering with their participation in therapy and clinical improvement. While there are various treatment options available for this condition, such as the intra-articular corticosteroid injection, not all patients are suitable and symptoms may persist despite multimodal analgesia. The ultrasound-guided genicular nerve block (US GNB) induces analgesia by targeting the genicular nerves around the knee, and has emerged as a safe and effective intervention option. This is the first effort to document its application in the inpatient rehabilitation setting.

Methods: This was a retrospective case series. We reviewed the medical records of inpatients undergoing rehabilitation who underwent the US GNB for disabling knee OA between July 1, 2022, and August 31, 2023. The primary outcome was improvement in rehabilitation participation based on physiotherapist notes in the week following the procedure. Secondary outcomes were pain by visual analogue scale (VAS), ambulation distance, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC), at pre-discharge, 1-month, and 3-month follow-up timepoints. Safety and adverse events were also retrospectively reviewed.

Results: Nine patients were consented for recruitment in our study. Eight of them showed improvement in pain and/or participation in therapy. There were significant improvements in VAS scores (median change -3) and improvements in ambulation distance (median increase 8 m) between pre-injection and pre-discharge phases. However, these did not persist at the longer follow-up visits. There were no serious adverse events although 3 patients had recurrent pain at later dates, and required further procedures or surgical referral.

Conclusions: The US GNB is safe to perform for inpatients undergoing rehabilitation who experience pain from knee OA. We found that in nearly all patients, there was clinical improvement in their pain and participation in therapy. It can be an effective alternative when other analgesia options are less desirable or available, and can help to keep patients progressing on the road to recovery.

床边超声引导下膝神经阻滞用皮质类固醇和利多卡因治疗膝骨关节炎可改善疼痛和参与,并且在住院康复中是安全的:回顾性病例系列。
背景:膝骨关节炎(OA)是一种常见的关节疾病,可引起明显的疼痛和残疾。它可以影响正在接受住院康复的个体,干扰他们参与治疗和临床改善。虽然有多种治疗方案可用于这种情况,如关节内皮质类固醇注射,但并非所有患者都适用,尽管采用多种模式镇痛,症状仍可能持续存在。超声引导的膝神经阻滞(US GNB)通过靶向膝关节周围的膝神经来诱导镇痛,是一种安全有效的干预选择。这是第一次努力记录其在住院康复设置中的应用。方法:回顾性研究。我们回顾了2022年7月1日至2023年8月31日期间因致残膝关节OA而接受美国GNB的住院康复患者的医疗记录。主要结果是康复参与程度的改善,基于理疗师在手术后一周的记录。次要结果是在出院前、随访1个月和3个月的时间点,通过视觉模拟量表(VAS)、行走距离、西安大略省和麦克马斯特大学关节炎指数(WOMAC)测量疼痛。安全性和不良事件也进行了回顾性评价。结果:9例患者被同意纳入我们的研究。其中8人表现出疼痛和/或参与治疗的改善。注射前和出院前两阶段的VAS评分均有显著改善(中位数变化为-3),行走距离也有显著改善(中位数增加8 m)。然而,这些在较长时间的随访中并没有持续存在。虽然有3例患者后来出现复发性疼痛,需要进一步的手术或外科转诊,但没有出现严重的不良事件。结论:US GNB对于经历膝关节OA疼痛的住院康复患者是安全的。我们发现几乎所有的病人,他们的疼痛和参与治疗都有临床改善。当其他镇痛方法不太理想或可用时,它可以是一种有效的替代方法,并且可以帮助患者在康复的道路上取得进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信